REBEL REAVIS: Open Payments
NPI 1811753460 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $517 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Lundbeck LLC | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: QULIPTA, REXULTI, GVOKE HYPOPEN, VRAYLAR, BREZTRI, UBRELVY, TRELEGY ELLIPTA.
Industry payments across NM — which companies pay providers there.
